← Pharmacy curriculum
Module 1349 lessonsRxPrep 2023 Chapter 39 reconciled with current CDC pinworm guidance and current DailyMed mebendazole and pyrantel pamoate labeling

Pinworm Infection

Connect the Enterobius life cycle, nocturnal symptoms, tape-test diagnosis, anthelmintic pharmacology, dose calculations, repeat treatment, household control, and reinfection prevention.

01

Explain how nocturnal egg deposition, hand-to-mouth transfer, and environmental persistence sustain household transmission.

02

Recognize the characteristic symptom pattern while preserving a differential for perianal itching, sleep disruption, and vulvovaginal symptoms.

03

Teach a three-morning tape test and explain why stool, blood, urine, and routine swab testing are usually low yield.

04

Calculate pyrantel pamoate dosing from pyrantel base, body weight, product concentration, and the one-gram maximum dose.

05

Compare pyrantel pamoate, mebendazole, and albendazole by mechanism, regimen, administration, availability, and safety.

06

Explain why the second dose is given two weeks after the first and why treatment failure often reflects reinfection rather than resistance.

07

Coordinate simultaneous household treatment and a practical hygiene plan through two weeks after the final dose.

08

Adjust decisions for young children, pregnancy, lactation, liver disease, swallowing ability, interacting medicines, and uncertain diagnosis.

09

Monitor symptom resolution, exposure control, adverse effects, adherence, and referral triggers after the repeat dose.

134.01

Follow the Egg, Not Just the Worm

Enterobius vermicularis spreads when infective eggs reach the mouth. Nocturnal migration, rapid egg maturation, scratching, contaminated hands, and shared surfaces create a repeatable household cycle.

What to learn
  • Enterobius
  • Nocturnal migration
  • Egg maturation
  • Autoinfection
  • Fomites
Transmission loopFollow eggs from nocturnal deposition to hand-to-mouth reinfection
01DepositPerianal skin at night

Eggs create itching and surface contamination

02TransferHands and nails

Scratching moves eggs to fingers and objects

03IngestMouth

Swallowed eggs restart intestinal infection

04PersistHousehold objects

Eggs can remain viable for weeks

Begin in the colon

Adult worms inhabit the intestinal tract. At night, a gravid female migrates to perianal skin and deposits eggs, which produces the characteristic nocturnal itch.

Make eggs infective

Eggs can become infective within hours. Scratching transfers them under fingernails, and hand-to-mouth contact restarts infection in the same person or spreads it to others.

Recognize environmental persistence

Eggs can survive on clothing, bedding, toys, bathroom surfaces, and other objects for roughly two to three weeks when they are not removed.

Keep the host specific

Human pinworm is not acquired from household pets. Pool transmission is considered very unlikely, so counseling should focus on hands, nails, bathing, clothing, and shared household items.

0 of 1 answered
01Which event most directly restarts the pinworm life cycle in a household?
Answer every question to submit.
134.02

Recognize the Pattern Without Anchoring

Many infections are asymptomatic. The classic presentation is persistent nocturnal perianal pruritus, but the same symptom can arise from inflammatory, infectious, structural, behavioral, or safeguarding concerns.

What to learn
  • Nocturnal pruritus
  • Sleep disruption
  • Vulvovaginal symptoms
  • Differential
  • Red flags
Pattern recognitionUse timing and morphology to separate classic disease from important mimics
01SupportNocturnal perianal itch

Sleep disruption and household clustering raise probability

02InspectSkin and local anatomy

Rash, fissure, abscess, or bleeding may redirect care

03ExtendGenital and abdominal symptoms

Migration and alternative disease require assessment

04EscalateSevere or atypical

Fever, pain, weight loss, or persistence needs review

Ask about timing

Itching that is strongest at night, restless sleep, irritability, and affected household contacts support pinworm. Direct observation may reveal small white worms two to three hours after sleep begins.

Examine the local pattern

Excoriation may follow scratching. A moist beefy rash, burrows, sharply demarcated dermatitis, fissure, bleeding, severe pain, drainage, or a persistent mass points toward another or additional disorder.

Include genital symptoms

Female genital-tract migration can rarely cause vulvar or vaginal inflammation. Discharge, pelvic pain, dysuria, bleeding, abuse concern, or recurrent symptoms requires appropriate clinical assessment.

Escalate atypical disease

Fever, weight loss, severe abdominal pain, vomiting, neurologic symptoms, significant bleeding, immunocompromise, or failure after correctly completed treatment should trigger diagnostic review.

0 of 1 answered
01Which finding most strongly supports uncomplicated pinworm infection?
Answer every question to submit.
134.03

Collect Before the Morning Routine

The cellulose tape test samples eggs from perianal skin. Timing and repeated collection matter because routine stool and blood tests usually do not capture the organism.

What to learn
  • Tape test
  • Three mornings
  • Before bathing
  • Microscopy
  • Low-yield tests
Three-morning collectionPreserve perianal eggs before the morning routine and improve detection through repetition
01TimeImmediately after waking

Before bathing, toileting, or dressing

02SampleSticky tape to perianal skin

Follow the laboratory collection kit

03RepeatThree consecutive mornings

Intermittent deposition can be missed once

04ProtectContain and wash hands

Reduce collector and household transfer

Choose the right moment

Press the sticky side of clear tape against perianal skin first thing in the morning before bathing, toileting, or dressing.

Repeat collection

Collect on three consecutive mornings to improve the chance of sampling intermittent egg deposition. Follow the laboratory's slide, container, transport, and labeling instructions.

Protect the collector

Avoid touching the face during collection, contain the specimen, and wash hands thoroughly afterward. Handle clothing and bedding carefully.

Avoid low-yield substitutions

Routine stool, urine, vaginal, anorectal, and blood testing generally does not contain enough eggs or worms to diagnose pinworm. There is no blood test for pinworm.

0 of 1 answered
01When should a tape test be collected?
Answer every question to submit.
134.04

Calculate the Active Base

OTC pyrantel pamoate produces neuromuscular paralysis of susceptible worms. Safe dosing requires the patient's weight, the dose in pyrantel base, the maximum, and the exact product concentration.

What to learn
  • Pyrantel base
  • Neuromuscular blockade
  • 11 mg per kg
  • Maximum 1 g
  • Concentration
Active-base calculationMove from body weight to pyrantel base and then to the exact product volume
01WeighKilograms

Use a current measured weight

02Dose11 mg per kg

Express the result as pyrantel base

03CapMaximum 1,000 mg

Apply before converting the product

04ConvertBase concentration

Divide milligrams by milligrams per milliliter

Use the current regimen

CDC lists pyrantel pamoate 11 mg per kg orally, up to 1 gram of pyrantel base, followed by the same dose two weeks later.

Read the Drug Facts panel

Products may state pyrantel pamoate salt and its pyrantel-base equivalent. Suspensions commonly contain 50 mg of pyrantel base per milliliter, but the exact label controls.

Convert in sequence

Multiply kilograms by 11 mg per kg, apply the 1,000 mg maximum, then divide by the product's base concentration. Round only as the measuring device and label permit.

Counsel expected effects

Abdominal cramps, nausea, vomiting, diarrhea, headache, or dizziness can occur. Pregnancy, breastfeeding, liver disease, very young age, or persistent symptoms requires clinician or label-directed review.

0 of 1 answered
01A 30 kg child uses a suspension containing 50 mg pyrantel base per mL. What volume provides 11 mg per kg?
Answer every question to submit.
134.05

Separate the Benzimidazole Regimens

Mebendazole and albendazole disrupt parasite microtubule-dependent processes, but their labeled status, administration, age evidence, interaction profile, and pinworm regimens are not interchangeable.

What to learn
  • Mebendazole
  • Albendazole
  • Microtubules
  • Administration
  • Metronidazole
Benzimidazole precisionKeep organism-specific regimens, administration, and interaction rules distinct
01Mebendazole100 mg once

Repeat in two weeks

02InteractionAvoid metronidazole

Serious skin reactions have been reported

03Albendazole400 mg once

Take on an empty stomach for pinworm

04ReviewPatient and product

Age, pregnancy, liver, allergy, and medicines matter

Use mebendazole precisely

CDC lists mebendazole 100 mg orally once and repeated in two weeks. Current EMVERM labeling covers patients two years and older; its tablet can be chewed, swallowed, or crushed and mixed with food.

Avoid a serious interaction

Current mebendazole labeling advises avoiding concurrent metronidazole because serious skin reactions have been reported. Medication reconciliation remains necessary even for a single dose.

Use albendazole for this infection

CDC lists albendazole 400 mg orally once on an empty stomach and repeated in two weeks. This administration differs from systemic tissue infections in which food may intentionally raise exposure.

Keep safety proportional

Short pinworm regimens are usually tolerated, but gastrointestinal effects, headache, hepatic risk, allergy, pregnancy, lactation, pediatric age, and interacting therapy still influence selection.

0 of 1 answered
01Which administration instruction is specific to CDC's albendazole regimen for pinworm?
Answer every question to submit.
134.06

Design the Two-Dose Plan

Available medicines kill susceptible worms but do not reliably kill eggs. The two-week repeat dose targets worms that hatch after the first treatment.

What to learn
  • Egg survival
  • Two weeks
  • Adherence
  • Household timing
  • Reinfection
Two-dose logicTarget active worms now and worms that hatch after surviving eggs
01Day 0First treatment

Reduce the active worm burden

02BetweenControl egg transfer

Coordinate hands, nails, bathing, and laundry

03Day 14Repeat treatment

Target newly hatched worms

04AuditIf symptoms return

Check dose, household, exposure, and diagnosis

Explain the gap

The first dose reduces the active worm burden. Eggs already present can survive, hatch, and mature, so the scheduled repeat dose is part of the intended regimen rather than rescue for failure.

Schedule immediately

Record both calendar dates, verify enough product for both doses, and make the second dose visible in reminders and caregiver instructions.

Coordinate the household

Treat the infected person, caregivers, and household members at the same time when current guidance recommends it, unless an individual requires separate clinical review.

Interpret recurrence

Symptoms after treatment can reflect missed repeat dosing, underdosing, wrong concentration, incomplete household treatment, ongoing egg exposure, or another diagnosis before they imply drug resistance.

0 of 1 answered
01Why is a second pinworm dose given two weeks after the first?
Answer every question to submit.
134.07

Control the Household Without Creating Panic

Medication and hygiene work together. High-value actions remove eggs from hands, nails, skin, clothing, bedding, and commonly handled items while avoiding unnecessary or hazardous cleaning.

What to learn
  • Handwashing
  • Morning shower
  • Short nails
  • Hot laundry
  • Two-week window
Household controlPair simultaneous treatment with a sustainable two-week hygiene sequence
01HandsSoap and warm water

After toilet and diaper care, before food

02MorningShower and change

Remove eggs deposited overnight

03LaundryHandle gently and heat

Avoid shaking fabrics

04SustainTwo weeks after last dose

Prevent the cycle from restarting

Lead with hands

Wash with soap and warm water after toileting, diaper changes, contact with affected people or items, and before food handling. Keep nails short and clean, and discourage scratching and nail biting.

Remove overnight eggs

Shower each morning, change underwear and sleepwear, and avoid shared bathwater or washcloths. A shower is preferred over a tub bath for reducing spread.

Handle fabrics carefully

Change and hot-wash clothing, towels, washcloths, and bedding without shaking them. CDC prevention guidance specifies water at least 130 degrees Fahrenheit followed by a hot dryer.

Sustain the window

Continue household measures for two weeks after the last treatment dose. Prioritize repeatable behavior over excessive disinfectant use, pesticide exposure, or disposal of possessions.

0 of 1 answered
01Which household plan best reduces reinfection?
Answer every question to submit.
134.08

Widen the Margin When Evidence Is Limited

Young age, pregnancy, lactation, liver disease, swallowing limitations, neurologic history, allergy, and interacting therapy change the treatment margin.

What to learn
  • Under age two
  • Pregnancy
  • Lactation
  • Liver disease
  • Shared decisions
Reserve and exposureChildren, older adults, pregnancy, lactation, and fragile skin require product-specific selection rather than one universal rule
01ChildrenHigher surface area relative to mass

Systemic exposure can rise

02Older skinAtrophy and purpura risk

Use a deliberate site and duration plan

03PregnancySmallest effective exposure

Use current product evidence, not retired letters

04LactationPrevent infant contact and ingestion

Nipple use requires a feeding plan

Adapt without abandoning protectionAge, pigment, sensitivity, pregnancy, lactation, and heat change the plan
01InfantShade and clothing first

Prevent overheating

02PigmentTint and iron oxides

Visible-light protection can matter

03SensitiveTolerated formulation

Vehicle and ingredients differ

04ReproductiveProduct-specific assessment

Retired letters do not decide care

Adapt the planAge, skin tone, hair texture, pregnancy, lactation, immune status, and neurologic disease alter assessment and delivery
01InfantCradle cap

Gentle scale care, no adult shampoo assumption

02HairCoils and protective styles

Build a feasible scalp schedule

03Skin toneErythema may look different

Track pigment change and texture

04HostImmune or neurologic risk

Lower the threshold for evaluation

Change the safety marginAge, prematurity, diarrhea, antibiotics, immune status, mobility, and incontinence alter exposure and risk
01NewbornThin immature barrier

Lower threshold for clinical review

02DiarrheaFrequent enzyme-rich stool

Change and protect more often

03AntibioticCandida risk rises

Use morphology, not prophylactic antifungal

04Older child or adultIncontinence-associated dermatitis

Pressure and wound care may coexist

Individual safetyCoordinate household care without erasing drug-specific differences
01ChildExact age and weight

Evidence and labeling differ below age two

02PregnancyCurrent risk-benefit review

Retired letter categories are not used

03LactationDrug-specific evidence

Mebendazole data differ from other options

04ComorbidityLiver, allergy, swallowing

Select product and plan individually

Protect young children

CDC advises weighing risks and benefits in children younger than two years. Current EMVERM labeling begins at age two, and convulsions have been reported in infants below one year after mebendazole exposure.

Use current pregnancy reasoning

Do not use retired pregnancy letters. CDC notes limited pregnancy data and recommends considering treatment when infection meaningfully compromises the pregnancy, generally deferring until later pregnancy when clinically appropriate.

Review lactation by drug

CDC considers mebendazole exposure in milk minimal and breastfeeding compatible. Information for pyrantel and albendazole is less complete, so use drug-specific evidence and shared decision making.

Screen the individual

Review liver disease, allergy, formulation, swallowing, interacting medicines, exact age and weight, symptom burden, diagnosis certainty, and the consequence of delaying therapy.

0 of 1 answered
01What is the best approach for a household member who is pregnant?
Answer every question to submit.
134.09

Close the Loop After the Repeat Dose

Successful management combines symptom improvement, completion of both doses, household coordination, hygiene execution, adverse-effect review, and reassessment of persistent or atypical disease.

What to learn
  • Symptom trend
  • Second dose
  • Reinfection
  • Adverse effects
  • Referral
Close the loopDistinguish response, reinfection, execution failure, toxicity, and a wrong diagnosis
01TrendItch, sleep, worms

Measure change after each dose

02VerifyDose and household

Confirm both dates and calculations

03RecheckHygiene and exposure

Childcare and household cycles can persist

04ReferAtypical or unresolved

Broaden the diagnosis and assess toxicity

Measure the clinical response

Track nocturnal itching, sleep, visible worms, excoriation, genital symptoms, affected contacts, and adverse effects after each dose.

Audit the regimen

Verify patient weight, active-base calculation, product concentration, first and second dose dates, administration, vomiting, interacting medicines, and simultaneous household treatment.

Audit exposure control

Review handwashing, nail care, morning bathing, clothing and bedding handling, childcare or institutional exposure, and the full two-week hygiene period after the final dose.

Reconsider the diagnosis

Persistent symptoms after a correctly executed plan, severe pain, bleeding, fever, discharge, abdominal symptoms, neurologic findings, treatment toxicity, or repeated outbreaks require clinician or public-health evaluation.

0 of 1 answered
01What is the best first step when itching persists after treatment?
Answer every question to submit.

Check the connections.

Each attempt draws 10 questions from the complete 112 question bank.

112 questions in this module bank10 questions per attempt

Each attempt draws a fresh set and rearranges the answer choices.

Current clinical foundation.

Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.

  1. CDC Clinical Overview of Pinworm Infection
  2. CDC Diagnosing Pinworms
  3. CDC Preventing Pinworm Infection
  4. DailyMed EMVERM Prescribing Information
  5. DailyMed Pyrantel Pamoate Suspension
PharmacyOpen tools